Medtronic PLC
XMUN:2M6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Economic Moat
Medtronic has a narrow economic moat
Patented device designs and the time needed to learn and replace connected medical systems make it harder for rivals to take Medtronic’s customers. These protections are strongest in complex implants and surgical equipment, rather than across every product it sells. Established competitors still offer alternatives in many of its markets.
What protects Medtronic from competitors
High Switching Costs
Medtronic’s connected surgical equipment combines planning, imaging and guidance, while its implanted heart devices use compatible programming and monitoring tools. Replacing these systems can require new equipment, staff training and changes to established procedures, making a cheaper rival less attractive.
Intangible Assets
Medtronic’s patents protect device designs from direct copying, while regulatory approvals require would-be competitors to establish the safety and effectiveness of their own products. Together, these barriers give its protected devices time to earn profits before similar alternatives reach customers.
What could weaken Medtronic's moat
2 risks to watch
One for each source of the moat: what could happen and how it would weaken it
Peer Comparison
2 of 6 peers have a wide moat.
Stryker SYK
Wide
High Switching Costs, Intangible Assets
Zimmer Biomet Holdings ZBH
Wide
High Switching Costs, Intangible Assets
Abbott Laboratories ABT
Narrow
High Switching Costs, Intangible Assets
Boston Scientific BSX
Narrow
High Switching Costs, Intangible Assets
Edwards Lifesciences EW
Narrow
High Switching Costs, Intangible Assets
Becton Dickinson and BDX
Narrow
High Switching Costs, Intangible Assets